New hope for pancreatic cancer: drug combo trial launches
NCT ID NCT07255404
First seen Dec 29, 2025 · Last updated Jun 19, 2026 · Updated 28 times
Summary
This study tests a new drug called BNT327 combined with standard chemotherapy in adults with metastatic pancreatic cancer that has not been treated before. The goal is to see if the combination shrinks tumors better than chemo alone. About 105 participants will be enrolled, and researchers will monitor side effects and how long any response lasts.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fudan University Shanghai Cancer Center
RECRUITINGShanghai, 201318, China
-
Henan Cancer Hospital
RECRUITINGZhengzhou, 450008, China
-
Huashan Hospital, Fudan University
RECRUITINGShanghai, 200040, China
-
Sichuan Cancer Hospital
RECRUITINGChengdu, 610041, China
-
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
RECRUITINGGuangzhou, 510000, China
-
The Affiliated Cancer Hospital of Guangxi Medical University
RECRUITINGNanning, 530200, China
-
The First Affiliated Hospital of Nanchang University
RECRUITINGNanchang, 330052, China
-
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
RECRUITINGWuhan, 430030, China
-
Tsinghua Changgung Hospital
RECRUITINGBeijing, 102218, China
-
Zhejiang Provincial People's Hospital
RECRUITINGHangzhou, 325200, China
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.